Showing results (101-110 of 141) with videos related to
Sort By:
Pageof 15
Bulletin Du Cancer|August 22, 2009
[Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status]Y Bensouda, F André, T Boulet, et al.Scientific Reports|September 23, 2018
Sun-induced fluorescence and gross primary productivity during a heat waveG Wohlfahrt, K Gerdel, M Migliavacca, et al.International Journal of Cancer|November 24, 1999
c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patientsM G Lê, M C Mathieu, S Douc-Rasy, et al.Bulletin Du Cancer|July 1, 1993
[Treatment of advanced breast cancer in postmenopausal women with droloxifene: results of a double-blind phase II trial for dose determination]B Chevallier, M Spielmann, M Marty, et al.Cancer|July 1, 1988
Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimenM Ghosn, J P Droz, C Theodore, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 30, 2009
Cost-effectiveness of adjuvant docetaxel for node-positive breast cancer patients: results of the PACS 01 economic studyP Marino, C Siani, H Roché, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomasA Le Cesne, E Antoine, M Spielmann, et al.American Journal of Clinical Oncology|April 1, 1994
Acute antiemetic efficacy and safety of dolasetron mesylate, a 5-HT3 antagonist, in cancer patients treated with cisplatin. European Dolasetron Study GroupT Conroy, P Cappelaere, M Fabbro, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder. The French Federation of Cancer Centers experienceA Boutan-Laroze, M Mahjoubi, J P Droz, et al.International Journal of Radiation Oncology, Biology, Physics|November 1, 1990
Alternating radiotherapy and chemotherapy in non-metastatic inflammatory breast cancerR Arriagada, H Mouriesse, M Spielmann, et al.Pageof 15